Literature DB >> 12742081

Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.

C Bonde1, A Sarup, A Schousboe, G Gegelashvili, J Zimmer, J Noraberg.   

Abstract

Maintenance of low extracellular glutamate ([Glu](O)) preventing excitotoxic cell death requires fast removal of glutamate from the synaptic cleft. This clearance is mainly provided by high affinity sodium-dependent glutamate transporters. These transporters can, however, also be reversed and release glutamate to the extracellular space in situations with energy failure. In this study the cellular localisation of the glutamate transporters GLAST and GLT-1 in organotypic hippocampal slice cultures was studied by immunofluorescence confocal microscopy, under normal culture conditions, and after a simulated ischemic insult, achieved by oxygen and glucose deprivation (OGD). In accordance with in vivo findings, GLAST and GLT-1 were primarily expressed by astrocytes under normal culture conditions, but after OGD some damaged neurons also expressed GLAST and GLT-1. The potential damaging effect of inhibition of the glutamate transporters by DL-threo-beta-benzyloxyaspartate (DL-TBOA) was studied using cellular uptake of propidium iodide (PI) as a quantitative marker for the cell death. Addition of DL-TBOA for 48 h was found to induce significant cell death in all hippocampal regions, with EC(50) values ranging from 38 to 48 microM for the different hippocampal subregions. The cell death was prevented by addition of the glutamate receptor antagonists NBQX and MK-801, together with an otherwise saturating concentration of DL-TBOA (100 microM). Finally, the effect of inhibition of glutamate release, via reverse operating transporters during OGD, was investigated. Addition of a sub-toxic (10 microM) dose of DL-TBOA during OGD, but not during the subsequent 48 h recovery period, significantly reduced the OGD-induced PI uptake. It is concluded: (1) that the cellular expression of the glutamate transporters GLAST and GLT-1 in hippocampal slice cultures in general corresponds to the expression in vivo, (2) that inhibition of the glutamate transporters induces cell death in the slice cultures, and (3) that partial inhibition during simulation of ischemia by OGD protects against the induced PI uptake, most likely by blocking the reverse operating transporters otherwise triggered by the energy failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742081     DOI: 10.1016/s0197-0186(03)00024-x

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  17 in total

1.  A novel method for inducing focal ischemia in vitro.

Authors:  Marc J P Richard; Tarek M Saleh; Bouchaib El Bahh; Jeffrey A Zidichouski
Journal:  J Neurosci Methods       Date:  2010-04-22       Impact factor: 2.390

Review 2.  Role of astrocytes in glutamate homeostasis: implications for excitotoxicity.

Authors:  Arne Schousboe; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

3.  Organotypic Hippocampal Slice Cultures As a Model to Study Neuroprotection and Invasiveness of Tumor Cells.

Authors:  Urszula Grabiec; Tim Hohmann; Niels Hammer; Faramarz Dehghani
Journal:  J Vis Exp       Date:  2017-08-27       Impact factor: 1.355

Review 4.  Astrocytic glycogen metabolism in the healthy and diseased brain.

Authors:  Lasse K Bak; Anne B Walls; Arne Schousboe; Helle S Waagepetersen
Journal:  J Biol Chem       Date:  2018-03-23       Impact factor: 5.157

5.  Glutamate uptake block triggers deadly rhythmic bursting of neonatal rat hypoglossal motoneurons.

Authors:  Elina Sharifullina; Andrea Nistri
Journal:  J Physiol       Date:  2006-02-02       Impact factor: 5.182

6.  Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia.

Authors:  M L Weller; I M Stone; A Goss; T Rau; C Rova; D J Poulsen
Journal:  Neuroscience       Date:  2008-06-17       Impact factor: 3.590

Review 7.  Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.

Authors:  Wagner Carbolin Martins; Carla Inês Tasca; Helena Cimarosti
Journal:  Neurochem Res       Date:  2015-07-31       Impact factor: 3.996

8.  Role of astrocytes in depolarization-coupled release of glutamate in cerebellar cultures.

Authors:  Lasse K Bak; Helle S Waagepetersen; Arne Schousboe
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 9.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

10.  Thrombin-facilitated efflux of D-[3H]-aspartate from cultured astrocytes and neurons under hyponatremia and chemical ischemia.

Authors:  M Pérez-Domínguez; R Hernández-Benítez; C Peña Segura; H Pasantes-Morales
Journal:  Neurochem Res       Date:  2014-04-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.